View in EDS

Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer.

Saved in:
Bibliographic Details
Title: Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer.
Authors: Roper N; Developmental Therapeutics Branch, Center for Cancer Research, NCI, Bethesda, Maryland., El Meskini R; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, NCI, Frederick, Maryland., Maity T; Thoracic and GI Malignancies Branch, Center for Cancer Research, NCI, Bethesda, Maryland., Atkinson D; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, NCI, Frederick, Maryland., Day A; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, NCI, Frederick, Maryland., Pate N; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, NCI, Frederick, Maryland., Cultraro CM; Thoracic and GI Malignancies Branch, Center for Cancer Research, NCI, Bethesda, Maryland., Pack S; Laboratory of Pathology, Center for Cancer Research, NCI, Bethesda, Maryland., Zgonc V; Laboratory of Pathology, Center for Cancer Research, NCI, Bethesda, Maryland., Weaver Ohler Z; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, NCI, Frederick, Maryland., Guha U; Thoracic and GI Malignancies Branch, Center for Cancer Research, NCI, Bethesda, Maryland.; NextCure Inc., Beltsville, Maryland.
Source: Cancer research communications [Cancer Res Commun] 2024 Feb 08; Vol. 4 (2), pp. 337-348.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2767-9764
DOI:10.1158/2767-9764.CRC-23-0321